Process for manufacture of lithium salts of bis (fluorosulfonyl) imides in solid form

The preparation process of LiFSI is simplified by the supercritical fluid extraction method, and the complex and impure preparation of LiFSI solid form in the prior art is solved, thereby achieving high purity and high yield LiFSI, which is suitable for battery electrolytes.

CN119053548AInactive Publication Date: 2024-11-29SPECIALTY OPERATIONS FRANCE SAS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380035030.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-21
Filing Date
2023-04-12
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The steps for preparing lithium bis(fluorosulfonyl)imide (LiFSI) solid form in the prior art are complicated, especially because the solvent needs to be removed, resulting in impurity in the product and difficult to meet the requirements of battery electrolytes.

Method used

Using a supercritical fluid extraction method, supercritical fluid is contacted as a countersolvent, LiFSI solution is contacted to remove solvents, and solid LiFSI is recovered, which simplifies the process and improves yield and purity.

Benefits of technology

It realizes the preparation of solid LiFSI with high purity and high yield, simplifies the process flow, is suitable for battery electrolytes, and is environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119053548A_ABST
    Figure CN119053548A_ABST
Patent Text Reader

Abstract

The present disclosure relates to a process for preparing a lithium salt of bis (fluorosulfonyl) imide (LiFSI) in solid form, wherein the LiFSI salt in solid form is extracted from a solution comprising at least one solvent by supercritical anti-solvent extraction. The invention also relates to LiFSI obtained therefrom in solid form, and to the use of such LiFSI in electrolytes for batteries.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority from the prior European patent application No. 22305585.6 filed on April 21, 2022, the entire contents of which are incorporated herein by reference for all purposes. Technical Field

[0003] The present invention relates to a method for preparing a lithium salt of bis(fluorosulfonyl)imide (LiFSI) in solid form. The present invention also relates to the solid LiFSI obtained therefrom and the use of such LiFSI in an electrolyte for a battery. Background Art

[0004] Bis(fluorosulfonyl)imide and its salts, in particular the lithium salt of bis(fluorosulfonyl)imide (LiFSI), are useful compounds in various technical fields, including in battery electrolytes.

[0005] The production of LiFSI is described in the literature. Of the different techniques described, most use a fluorination reaction with a fluorinating agent in a solvent.

[0006] Notably, WO 2017 / 090877 (in the name of CLS) describes a method for producing LiFSI, the method comprising the following steps: (1) reacting bis(chlorosulfonyl)imide with a fluorinating agent in a solvent, and then treating with an alkaline agent to produce ammonium bis(fluorosulfonyl)imide; and (2) reacting ammonium bis(fluorosulfonyl)imide with a lithium-based substance. The solvent used in step (1) is selected from the group consisting of: alkyl ketones including acetone, methyl ethyl ketone and methyl isopropyl ketone; alcohols including methanol, anhydrous ethanol, 1-propanol and isopropanol; alkyl nitriles including acetonitrile and propionitrile; and ethers including tetrahydrofuran and dialkoxyalkanes. The solvent is then removed by distillation and concentrated under reduced pressure.

[0007] WO 2012 / 117961 (in the name of Nippon Soda) describes a process for producing fluorosulfonyl imide salts. According to Examples 1 and 2, ammonium di(fluorosulfonyl)imide is prepared from di(chlorosulfonyl)imide in acetonitrile. The solvent is then removed by distillation under reduced pressure.

[0008] JP 2016145147 (in the name of Nippon Shokubai) relates to a method for providing a fluorosulfonyl imide compound represented by formula (1), which is carried out by reacting a compound represented by formula (2) and 1 to 3 equivalents of a compound represented by composition formula (3) in a stoichiometric amount based on 1 mol of the compound in the presence of a solvent in an amount of 0 to 4 times the mass of the compound.

[0009]

[0010] NH4F(HF) p (3)

[0011] Where R 1 It is C 1-6 Fluoroalkyl, R 6 Is halogen or C 1-6 Fluoroalkyl, Cat1 + and Cat2 + is a monovalent group, and p is an integer of 1 to 10.

[0012] JP 2014201453 (in the name of Nippon Shokubai Co., Ltd.) describes a method for producing an alkali metal salt of a fluorosulfonyl imide, the method comprising the steps of synthesizing an alkali metal salt of a fluorosulfonyl imide in the presence of a reaction solvent, the reaction solvent containing at least one solvent selected from the group consisting of: a carbonate-based solvent, an aliphatic ether-based solvent, an ester-based solvent, an amide-based solvent, a nitro-based solvent, a sulfur-based solvent and a nitrile-based solvent, and subsequently concentrating the alkali metal salt solution of the fluorosulfonyl imide by distilling off the reaction solvent in the coexistence of the reaction solvent and at least one poor solvent for the alkali metal salt of the fluorosulfonyl imide, the poor solvent being selected from the group consisting of: an aromatic hydrocarbon-based solvent, an aliphatic hydrocarbon-based solvent and an aromatic ether-based solvent, the concentrating step comprising the step of mixing the above-mentioned poor solvent with a reaction solution containing the reaction solvent and the alkali metal salt of the fluorosulfonyl imide.

[0013] Supercritical fluid extraction has been used for recycling purposes. Notably, US 2003 / 0186110 (in the name of ECO BATINDIANA LLC, ONTO TECH LLC), CN 105406146 (in the name of HARBIN INST TECHNOLOGY), and CN 110534835 (in the name of University of Changzhou) disclose a method for removing electrolyte from energy storage devices (e.g., lithium batteries) using supercritical fluids.

[0014] Supercritical fluid extraction for extracting bis(fluorosulfonyl)imide (HFSI) from a reaction mixture containing an acid has also been described. Notably, WO 2021 / 082450 (in the name of GUANGZHOU LIWENTECH CO LTD) discloses a method for purifying HFSI from a reaction mixture containing a strong acid (e.g., concentrated sulfuric acid, phosphoric acid) and a FSI salt (e.g., NaFSI, KFSI or LiFSI, etc.) using supercritical extraction (particularly supercritical CO2 fluid). In addition, CN 111517293 (in the name of SHANGHAI INST ORGANICCHEMISTRY CAS) describes a method for preparing HFSI using a supercritical fluid, the method comprising the following steps:

[0015]

[0016] Where X is an alkali metal; R 1 and R 2 and C1-12 alkyl substituted with F or all-F. Summary of the invention

[0017] As described in the literature, LiFSI is produced by fluorination in a solvent (eg, an organic solvent) to disperse reactive entities and react them.

[0018] However, such solvents need to be removed after the reaction to obtain products that are as pure as possible for battery applications.

[0019] The Applicant has realised that the steps for preparing LiFSI in solid form based on LiFSI in solution are complicated, not least because the amount of residual solvent must be as low as possible in order to be well suited for battery electrolytes.

[0020] The Applicant was therefore faced with the problem of developing a new process for producing LiFSI which allows overcoming the complexity of the processes known to date.

[0021] Unexpectedly, the applicant has developed a method for producing LiFSI which is simple to perform in terms of equipment and reaction conditions and is very friendly from an environmental point of view.

[0022] Furthermore, the process of the invention allows obtaining LiFSI in solid form with very high yield and high purity, so that it can then be used in battery electrolyte solutions.

[0023] An advantageous method according to the invention for preparing LiFSI in solid form is based on extraction with a supercritical fluid, which acts here as an anti-solvent for the LiFSI.

[0024] The object of the present invention is therefore a process for preparing LiFSI in solid form from a solution comprising at least one solvent and a LiFSI salt, which process is based on the use of a supercritical fluid. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 Scheme representing the laboratory setup used in Example 2. DETAILED DESCRIPTION

[0026] In this application:

[0027] - the expression "comprising between ... and ..." is to be understood as including the limit values;

[0028] - any description (even those relating to a specific embodiment) is applicable to and interchangeable with other embodiments of the invention;

[0029] - When an element or component is said to be included in and / or selected from a list of listed elements or components, it should be understood that in the relevant embodiments explicitly considered herein, the element or component may also be any of these listed independent elements or components, or may also be selected from a group consisting of any two or more of the explicitly listed elements or components; any element or component listed in the list of elements or components may be omitted from this list; and

[0030] - Any recitation of numerical ranges by endpoints herein includes all numbers subsumed within the recited range as well as the endpoints of that range and equivalents thereof.

[0031] A first object of the present invention relates to a method for preparing a lithium salt of bis(fluorosulfonyl)imide (LiFSI) in solid form, the method comprising the following steps:

[0032] a) injecting a supercritical fluid into a container;

[0033] b) optionally, injecting a solvent S into the container;

[0034] c) injecting a LiFSI solution comprising LiFSI and at least one solvent S into the container;

[0035] d) contacting the LiFSI solution with the at least one supercritical fluid and the solvent S in the container; and

[0036] e) recovering LiFSI in solid form.

[0037] The term "injecting" or "injection" herein means placing the fluids, solvents, and solutions described herein in a container (also referred to as a receiver or device) where the various components involved in the process will be contacted for LiFSI precipitation. In the context of the present invention, "injecting the fluid / solvent / solution into the container" may be replaced with "adding the fluid / solvent / solution to the container" or "feeding the fluid / solvent / solution into the container".

[0038] The term "contact" herein means that the solution is contacted with a supercritical fluid in a container under specific pressure and temperature conditions for a period of time sufficient for the fluid to remove at least a portion of the solvent present in the LiFSI solution, preferably greater than 80.0%, greater than 90.0%, greater than 95.0%, greater than 99.0%, greater than 99.5% or even greater than 99.9% of the solvent. This time is sufficient to allow LiFSI to precipitate in the container.

[0039] The term "recovery" herein means the removal or extraction of LiFSI in solid form from the vessel in which the process occurs.

[0040] The term "supercritical fluid" herein means a gas in its supercritical state. Depending on the gas used in step a), a certain pressure and temperature may be used in the vessel in which the contact between the solution and the supercritical fluid occurs. More specifically, the gas used in step a) is maintained at or above its critical temperature and critical pressure in order to be in a supercritical state.

[0041] The term "container" herein means a container that is well suited for the process of the present invention, that is, adapted to withstand the pressures and temperatures used in the process of the present invention, as well as the possible corrosive properties of the reactants and products involved in the process. As described in detail below, the container used in this article can notably be an extraction column (also called a "column") or an autoclave.

[0042] According to the method of the present invention, a supercritical fluid is used to extract the LiFSI salt from the solution, which has several advantages. Supercritical fluids, such as sCO2, have obvious advantages and are generally readily available, cheap, non-toxic, non-explosive, and not organic solvents. In addition, the method of the present invention operates at moderate temperatures (below 100°C), which ensures gentle handling of the LiFSI product. The method of the present invention also allows easy separation of one or more solvents and solid form extracts. The method of the present invention provides additional advantages described below, including the possibility of fine-tuning the size of the LiFSI salt obtained by the method of the present invention.

[0043] Preferably, the process according to the invention is carried out in a vessel at a pressure P of at least 73 bar (7.3 MPa).

[0044] Preferably, the process according to the invention is carried out in a container at a temperature T between 30°C and 90°C.

[0045] The temperature T in the container may vary between 37°C and 75°C, for example between 38°C and 70°C or between 40°C and 65°C.

[0046] The pressure P in the container may be at least 80 bar (8.0 MPa), at least 100 bar (10.0 MPa), at least 130 bar (13.0 MPa) or at least 150 bar (15.0 MPa). Very high pressures may also be used in the process of the invention, for example, the pressure P in the container may be up to 200 bar (20.0 MPa) or 300 bar (30.0 MPa). The pressure in the container will typically be less than 500 bar (50.0 MPa), for example less than 450 bar (45.0 MPa), less than 400 bar (40.0 MPa), or even less than 350 bar (35.0 MPa).

[0047] Preferably, each of the at least one supercritical fluid, solvent S and LiFSI solution is injected into the container through a syringe or an inlet valve installed on the container. Each of them can be injected into the container through the same syringe or inlet valve, or through different syringes or inlet valves.

[0048] Each of the at least one supercritical fluid, the solvent S, and the LiFSI solution may be independently injected into the container after the container is heated and / or pressurized.

[0049] When carrying out step b), preferably, step a) and b) are carried out simultaneously. The injection of supercritical fluid and solvent S according to this embodiment can be carried out by the same inlet valve or syringe (for example, coaxial nozzle can be used), or they can be carried out by different inlet valves or syringes (two or more).

[0050] Alternatively, step b) starts after step a).When solvent S starts to be injected in the container at step b), the injection of supercritical fluid according to step a) can preferably continue.Alternatively, the injection of supercritical fluid according to step a) can be stopped temporarily and restarted after a certain period of time.As disclosed above, the injection of supercritical fluid and solvent S according to these embodiments can be carried out by identical inlet valve or syringe, or they can be carried out by different inlet valves or syringes (two or more).

[0051] When both steps a) and b) are carried out, the supercritical fluid and the solvent S are mixed together.

[0052] The solvent S in step b) and the solvent S in the LiFSI solution in step c) may be the same as or different from each other. Preferably, the solvent S in step b) is the same as the solvent S in the LiFSI solution in step c).

[0053] According to step c), a LiFSI solution comprising LiFSI and solvent S is injected into the container. The LiFSI solution involved in the method of the present invention can be directly obtained from a LiFSI preparation method (as described, for example, in the experimental part of the present invention), or it can be a commercial product.

[0054] In step c) of the present invention, the LiFSI solution is injected into a container containing at least one supercritical fluid.

[0055] In step c), the LiFSI solution can be injected into the container via appropriate means (such as a nozzle or a syringe). According to a preferred embodiment, a capillary can be used to inject the LiFSI solution. Other means can be used to inject the LiFSI solution, such as an atomizing nozzle.

[0056] According to a preferred embodiment, the method of the present invention comprises step a) and step c). In other words, step b) is not performed. In this embodiment, the LiFSI solution is injected into a container containing a supercritical fluid. This injection is performed at a high flow rate for a short period of time, which helps to mix with the supercritical fluid in the container.

[0057] Alternatively, the method of the present invention comprises: step a), optionally step b) and step c), wherein step a), step c) and optionally step b) are performed simultaneously. In this embodiment, the LiFSI solution is injected into the container simultaneously with the supercritical fluid and optionally with the solvent S. For example, and particularly preferably on an industrial scale, the supercritical fluid and the LiFSI solution are introduced into the container simultaneously using a coaxial nozzle.

[0058] Alternatively, the method of the present invention comprises: step c), step a) and optionally step b). In this embodiment, the LiFSI solution is injected into the container before any one of the supercritical fluid and the optional solvent S. Preferably, the LiFSI solution is first introduced into the container, and then the container is heated and placed under pressure, and then the supercritical fluid and the optional solvent S are injected.

[0059] Preferably, step a) is performed by injecting a supercritical fluid at the bottom of the container. Advantageously, this allows improved mixing of the LiFSI solution with the supercritical fluid.

[0060] According to an embodiment, when step b) is performed, step b) is stopped at the start of step c). In other words, the feed of solvent S in the container is replaced by the feed of LiFSI solution. For example, the inlet valve or syringe for injecting solvent S into the container can be closed, while the inlet valve or syringe for injecting LiFSI solution into the container is opened. Alternatively, the same inlet valve or syringe is used for the feed of solvent S and LiFSI solution; in other words, the feed of LiFSI solution is injected into the container through the same inlet valve or syringe as solvent S.

[0061] As explained, during the process of the invention, the LiFSI solution is brought into contact with at least one supercritical fluid.

[0062] Preferably, the LiFSI solution is contacted with a fluid in a supercritical state.

[0063] Preferably, the LiFSI solution is contacted with two or more fluids in a supercritical state. The two or more fluids may be mixed, or may be contacted with the LiFSI solution in sequence. As an example, the LiFSI solution may be contacted with a mixture of at least two supercritical fluids.

[0064] Furthermore, according to the present invention, at least one other component (also referred to herein as a modifier) ​​may be mixed into the one or more supercritical fluids.

[0065] Preferably, the at least one other component is selected from polar solvents having a solubility in the supercritical fluid of less than 10 wt. % based on the total weight of the supercritical fluid and the one or more other components.

[0066] More preferably, when the at least one other component is used, its amount is in the range of 0.1 to 10.0 wt.%, eg, 0.5 to 8.0 wt.% or 1.0 to 6.0 wt.%, based on the total weight of the supercritical fluid plus the one or more other components.

[0067] Preferably, the at least one other component is selected from polar solvents, more preferably from the group comprising alcohols, toluene, dimethyl sulfoxide (DMSO), acetonitrile, etc. According to a preferred embodiment, the polar solvent is an alcohol. Even more preferably, the alcohol is ethanol.

[0068] Preferably, the supercritical fluid used in step a) comprises supercritical carbon dioxide (sCO2). sCO2 is a fluid state of carbon dioxide maintained at or above its critical temperature (31.0°C) and critical pressure (7.3773MPa).

[0069] Advantageously, the supercritical fluid used in step a) consists essentially of sCO2, or it comprises sCO2.

[0070] According to an embodiment, sCO2 is mixed with up to 10 wt.% ethanol, for example with 0.1 to 8 wt.% ethanol, the wt.% being based on the total weight of the supercritical fluid and the ethanol.

[0071] The weight ratio of the supercritical fluid to the LiFSI solution used in the method of the present invention may vary between 1 / 1 and 4000 / 1. For example, the weight ratio of the supercritical fluid / LiFSI solution preferably varies between 10 / 1 and 3500 / 1.

[0072] It will be clear to a person skilled in the art that the parameters of the process according to the invention may be appropriately selected and optimized based on, for example, the starting materials (particularly based on the purity of the product), and the scale on which the process is carried out, e.g. whether the process is carried out on an industrial scale or on a laboratory scale.

[0073] Preferably, when the method of the present invention is carried out on a laboratory scale, the mass ratio between the supercritical fluid and the solution containing LiFSI is:

[0074] - between 21 and 1500 when the injection of the solution containing LiFSI is continuous; or

[0075] - between 350 and 3100 when the injection of the solution containing LiFSI is discontinuous or batchwise.

[0076] Preferably, when the method of the present invention is carried out on an industrial scale, the mass ratio between the supercritical fluid and the solution containing LiFSI is lower than 300 when the injection of the solution containing LiFSI is continuous.

[0077] Good results were obtained at laboratory scale, as demonstrated in the following experimental section, where a supercritical fluid (preferably comprising or consisting of sCO2) was injected into a container at a flow rate between 5 and 50 g / min, preferably between 10 and 40 g / min, for example at about 30±5 g / min.

[0078] Good results have been obtained on a laboratory scale by injecting sCO2 into the container in step a) at a flow rate between 5 and 50 g / min, preferably about 30±5 g / min.

[0079] Good results have been obtained on a laboratory scale by injecting the at least one solvent S into the container in step b) at a flow rate of less than 1 mL / min, or less than 0.5 mL / min, preferably less than 0.1 mL / min.

[0080] The solution containing LiFSI includes one solvent S or two or more solvents S, for example, a mixture of two or three solvents S.

[0081] Preferably, the solvent S is selected from the group consisting of ethylene carbonate, propylene carbonate, butylene carbonate, γ-butyrolactone, γ-valerolactone, dimethoxymethane, 1,2-dimethoxyethane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,3-dioxane, 4-methyl-1,3-dioxolane, methyl formate, methyl acetate, methyl propionate, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, sulfolane, 3-methylsulfolane, dimethyl sulfoxide, N,N-dimethylformamide, N-methyloxazolidinone, acetonitrile, valeronitrile, benzonitrile, ethyl acetate, isopropyl acetate, n-butyl acetate, nitromethane, nitrobenzene, trifluoroethanol and mixtures thereof.

[0082] Preferred solvents include ethylene carbonate, propylene carbonate, butylene carbonate, tetrahydrofuran, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, ethyl acetate, isopropyl acetate and n-butyl acetate. Even more preferred solvents include dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, ethyl acetate, isopropyl acetate and n-butyl acetate. Still more preferred solvents include ethyl methyl carbonate and n-butyl acetate. The most preferred solvent is ethyl methyl carbonate.

[0083] In some embodiments, the solution comprises between 5 and 70 wt. % LiFSI based on the total weight of the LiFSI solution.

[0084] The LiFSI solution preferably comprises between 10 and 60 wt.%, such as between 15 and 50 wt.%, between 20 and 40 wt.% or between 25 and 35 wt.% LiFSI. As an example, the solution comprises 30±2 wt.% LiFSI.

[0085] Good results were obtained at laboratory scale by injecting the LiFSI solution into the container in step c) at a flow rate of less than 3 mL / min, less than 2.5 mL / min, preferably less than or equal to 2 mL / min.

[0086] In step c), the LiFSI solution may be provided sequentially, semi-continuously or continuously. In other words, the LiFSI solution is continuously injected into the container, or the LiFSI solution is semi-continuously injected into the container. For example, the LiFSI solution may be injected into the container for a certain period of time (e.g., between 30 seconds and 120 seconds, preferably about 60 seconds), and then the injection may be stopped for another period of time, which may be equal to, shorter than, or longer than the injection time. The LiFSI solution to be converted into a solid form may be injected into the container in 5, 4, 3, 2, or all at once.

[0087] A particular advantage of the process of the present invention is the short contact time in step d). Furthermore, advantageously, the contact time in step d) can be appropriately selected, for example, based on the starting material and the desired yield.

[0088] Preferably, the contact time in step d) varies between a few seconds (e.g. 5 seconds) and 24 hours. More preferably, the contact time in step d) varies between 1 minute and 12 hours, such as between 5 minutes and 10 hours or between 10 minutes and 5 hours.

[0089] When step d) is completed, LiFSI is recovered in step e) in solid form.

[0090] Preferably, the LiFSI in solid form recovered in step e) is in the form of a powder.

[0091] Preferably, step e) is performed by continuously or semi-continuously removing solid LiFSI from the container.

[0092] According to a specific embodiment of step e), the solid LiFSI is recovered and separated from the supercritical fluid. The pressure is released and the supercritical fluid becomes a gas. This gas is preferably recycled, as described in detail below.

[0093] Although the reaction conditions are controlled, at least a portion of the LiFSI in the LiFSI solution injected in step c) may not precipitate, and thus a portion of the LiFSI solution remains in the container to mix with the supercritical fluid. It will be appreciated by those skilled in the art that the LiFSI solution remaining in the container has a lower LiFSI concentration than the LiFSI solution provided in step c).

[0094] According to this embodiment, the mixture comprising the supercritical fluid, at least a portion of the LiFSI solution and optionally the solvent S is reinjected into the container as is.

[0095] Alternatively, a mixture comprising a supercritical fluid, at least a portion of the LiFSI solution and optionally a solvent S is injected into a second container. In the second container, the pressure is released, thereby obtaining a gas that can be further recycled into the process, and a solution of LiFSI and at least one solvent S that can be further reused in the process of the invention.

[0096] The method of the present invention can be carried out in batch mode, in continuous or semi-continuous mode. Preferably, the method is carried out in a continuous or semi-continuous manner.

[0097] The method of the present invention may further comprise additional steps.

[0098] For example, the method of the invention may comprise, after step d), a step d′ comprising injecting at least one supercritical fluid into the container. This additional step has the advantage of drying the LiFSI before recovering it in solid form in step e).

[0099] Preferably, said step d') is carried out at a pressure P of at least 73 bar and a temperature T between 10° C. and 90° C. After completion of step d'), the vessel can then be depressurized and the solid LiFSI product recovered in step e).

[0100] The method of the present invention may further comprise at least one step comprising recycling the solvent S and / or recycling the supercritical fluid after step d), step d′) or step e).

[0101] The process of the present invention preferably comprises recycling of the solvent S and recycling of the supercritical fluid.

[0102] Preferably, the supercritical fluid may be reinjected into the process of the invention as such or after an additional purification step or steps.

[0103] Preferably, the recycled solvent S can be reused in a different process (eg, an upstream process for preparing LiFSI salt).

[0104] The recycling of solvent S and supercritical fluid can be performed in several ways.

[0105] According to a first embodiment, the supercritical fluid may be recirculated in a continuous manner under pressure during the method using a supercritical fluid tube.

[0106] According to a second embodiment, the solvent S can be recovered as liquid phase by releasing the pressure in the container and then repressurizing the gas, for example by means of a compressor, in order to recirculate it as a supercritical fluid that can be discharged in the container.

[0107] The method of the present invention can be carried out in an apparatus comprising:

[0108] - Gas tanks and supercritical gas generators;

[0109] -optionally, a solvent S tank;

[0110] -LiFSI solution tank;

[0111] - a container which can withstand a pressure P of at least 50 bar (5.0 MPa) and a temperature T greater than 10° C.;

[0112] - a device for mixing the supercritical fluid and the LiFSI solution, such as an atomizing nozzle;

[0113] - at least two syringes mounted on the container; and

[0114] -Solvent trap;

[0115] -optionally, a separator; and

[0116] - Optionally, a filtering device.

[0117] The container may preferably be made of sapphire, SS316L, glass or graphite filled PTFE.

[0118] The container may notably be a column or an autoclave.

[0119] The apparatus may include a separator. Different separators may be used in the method of the present invention. In some embodiments, the separation of liquid and gas / fluid may be performed by conventional filtration (also referred to as "dead-end filtration") or cross filtration (also referred to as tangential filtration), as disclosed, for example, in US 2007 / 0021570 (in the name of Solvay SA). Alternatively, a cyclone separator may be used, such as those operated as a liquid / solid or gas / solid separator. A cyclone separator is advantageous because it allows the recovery of solids that may clog the filter medium. Several mixing devices exist based on this principle. Notably, reference may be made to patent US 7,410,620 (in the name of North Carolina State University).

[0120] For example, the frit filter may be made of stainless steel. Preferably, the frit filter has at least one of the following features: a pore size between 1 and 6 μm, preferably 2 to 4 μm; a diameter between 1 and 20 mm, preferably between 5 and 15 mm, more preferably about 10 mm; and / or a thickness between 0.1 and 5 mm, preferably between 0.7 and 3.5 mm, more preferably between 1.5 and 2.5 mm.

[0121] If the device comprises a filter or several filters, the filter or filters may notably be placed at the bottom or at the top of the container.

[0122] In an exemplary embodiment of the present invention, a method for preparing a LiFSI salt in solid form may be carried out at a laboratory scale and comprises:

[0123] a*) injecting sCO2 into a container at a flow rate comprised between 5 and 50 g / min, preferably about 30±5 g / min, wherein the container is at a pressure P of at least 73 bar and at a temperature comprised between 10° C. and 90° C., preferably at a pressure P of 200±10 bar and a temperature of 40° C.±5° C.;

[0124] b*) injecting solvent S into the container at a flow rate of less than 1 mL / min, preferably less than 0.1 mL / min;

[0125] c*) stopping the injection of solvent S according to step b) and injecting the LiFSI solution into the container at a flow rate of less than 3 mL / min, preferably less than or equal to 2 mL / min, wherein the LiFSI solution is injected into the container discontinuously (e.g., less than 5 times in the whole process);

[0126] d*) contacting the LiFSI solution with a supercritical fluid and a solvent S in a container for a period of between 5 minutes and 24 hours, preferably less than 5 hours; and

[0127] e*) Recovering LiFSI in solid form.

[0128] A second object of the present invention relates to the lithium salt of bis(fluorosulfonyl)imide (LiFSI) in solid form obtainable by the process of the present invention.

[0129] Advantageously, such a LiFSI salt in solid form is characterized in that it contains less than 100 ppm of water as measured according to the KF method (oven).

[0130] Preferably, the amount of water is less than 50 ppm, less than 40 ppm, less than 30 ppm, less than 20 ppm, less than 10 ppm, or even less than 5 ppm as measured according to the KF method (oven).

[0131] This LiFSI salt in solid form is also characterized in that the amount of solvent S in the salt is less than 50 ppm as measured by Li NMR. The amount of solvent S in LiFSI in solid form (e.g., in powder form) is preferably less than 40 ppm, less than 30 ppm, less than 20 ppm, less than 10 ppm, or even less than 5 ppm.

[0132] Advantageously, the LiFSI salt in solid form is characterized in that it contains at least one other substance. The other substance is preferably:

[0133] -Fluoride ion (F - ), preferably in an amount of less than 100 ppm as measured by ion chromatography (IC); and / or

[0134] -Chloride ion (Cl - ), preferably in an amount of less than 100 ppm as measured by IC; and / or

[0135] -Sulfate (SO4 2- ), preferably in an amount of less than 1,000 ppm as measured by IC; and / or

[0136] -sulfamate (NH2SO3 - ), preferably in an amount of less than 1,000 ppm as measured by IC; and / or

[0137] -Fluorosulfonate (FSO3 - ), preferably in an amount of less than 1,000 ppm as measured by IC.

[0138] Advantageously, the amounts of such other substances in the LiFSI salt in solid form recovered from the process of the present invention are preferably as follows:

[0139] -Fluoride ion (F - ), in an amount up to 50 ppm, such as less than 40 ppm, less than 30 ppm, less than 25 ppm;

[0140] -Chloride ion (Cl - ), in an amount up to 50 ppm, such as less than 40 ppm, less than 30 ppm, less than 20 ppm, less than 10 ppm or even less than 8 ppm;

[0141] -Different from sulfate (SO4 2- ) of acidic substances, the amount of which is up to 100 ppm, such as less than 50 ppm, less than 30 ppm, less than 25 ppm;

[0142] -Different from sulfate (SO4 2- ) of acidic substances in an amount up to 100 ppm, such as less than 50 ppm, less than 30 ppm, less than 10 ppm, less than 5 ppm;

[0143] These amounts were measured by ion chromatography (IC).

[0144] Preferably, the salt different from sulfate (SO4 2- ) is selected from NH2SO3 - and / or FSO3 - .

[0145] Preferably, the salt different from sulfate (SO4 2- ) is as follows:

[0146] - less than 50 ppm, e.g., less than 40 ppm, less than 30 ppm, less than 20 ppm, less than 10 ppm or even less than 5 ppm of sulfamate (NH2SO3 as measured by IC - ); and / or

[0147] - less than 50 ppm, such as less than 40 ppm, less than 30 ppm, less than 20 ppm, less than 10 ppm or even less than 5 ppm of fluorosulfonate (FSO3 - ).

[0148] The LiFSI salt of the present invention also preferably exhibits a content of at least one of the following chemical entities:

[0149] - an iron (Fe) content of less than 1,000 ppm, preferably less than 500 ppm, more preferably less than 100 ppm;

[0150] - a chromium (Cr) content of less than 1,000 ppm, preferably less than 500 ppm, more preferably less than 100 ppm;

[0151] - a nickel (Ni) content of less than 1,000 ppm, preferably less than 500 ppm, more preferably less than 100 ppm;

[0152] - a zinc (Zn) content of less than 1,000 ppm, preferably less than 100 ppm, more preferably less than 10 ppm;

[0153] - a copper (Cu) content of less than 1,000 ppm, preferably less than 100 ppm, more preferably less than 10 ppm;

[0154] - a bismuth (Bi) content of less than 1,000 ppm, preferably less than 100 ppm, more preferably less than 10 ppm;

[0155] - less than 10,000 ppm, preferably less than 5,000 ppm, more preferably less than 500 ppm, or even less than 100 ppm of sodium (Na + ) content; and / or

[0156] - less than 10,000 ppm, preferably less than 5,000 ppm, more preferably less than 500 ppm, or even less than 100 ppm of potassium (K + )content.

[0157] Indeed, the object of the present invention is to provide a LiFSI salt with a very low amount of impurities. The LiFSI salt of the present invention preferably exhibits a purity of greater than 99.50%, greater than 99.60%, greater than 99.70%, greater than 99.80%, greater than 99.90% and even greater than 99.95% as measured by Li-NMR.

[0158] A third object of the present invention relates to a powder comprising a lithium salt of bis(fluorosulfonyl)imide (LiFSI) and at least one other substance, wherein the at least one other substance is:

[0159] - solvent S, preferably less than 50 ppm as measured by Li NMR; and / or

[0160] - water, preferably in an amount of less than 50 ppm as measured by KF analysis via the oven method; and / or

[0161] -Fluoride ion (F - ), preferably in an amount less than 25 ppm; and / or

[0162] -Chloride ion (Cl - ), preferably in an amount less than 8 ppm; and / or

[0163] -Sulfate (SO4 2- ), preferably in an amount less than 20 ppm; and / or

[0164] -Different from sulfate (SO4 2- ) of acidic substances, preferably less than 1 ppm.

[0165] Preferably, the acidic substance is selected from NH2SO 3- and / or FSO3 - .

[0166] A fourth object of the present invention relates to the use of the lithium salt of bis(fluorosulfonyl)imide (LiFSI) according to the invention in solid form in a battery electrolyte solution.

[0167] A fifth object of the present invention is the use of supercritical antisolvent extraction for the preparation of LiFSI in solid form from a solution comprising a lithium salt of bis(fluorosulfonyl)imide (LiFSI) and at least one solvent S.

[0168] Should the disclosure of any patents, patent applications, and publications incorporated by reference into this application conflict with the description of this application to the extent that a term may be unclear, this description shall take precedence.

[0169] The present invention will now be described in more detail with reference to the following examples, which are for illustrative purposes only and are not intended to limit the scope of the present disclosure.

[0170] Examples

[0171] Example 1 - Preparation of LiFSI solution

[0172] The method for preparing the LiFSI solution is as follows.

[0173] The method is carried out in a 1L reactor with a stirring device, a double jacket for heat regulation, a condenser, a pressure regulator device and a liquid or gas addition device under N2. At room temperature, 577.18g of ethyl methyl carbonate (EMC) is introduced, and 145.77g of anhydrous NH4F is suspended. 190.52g of bis(chlorosulfonyl)imide (HCSI) with formula (Cl-SO2)2-NH is gradually added during 1 hour, and the mixture is heated to less than 75 ° during 18-20 hours under stirring. The mixture is cooled to room temperature, and 0.945g of 25% NH4OH (aqueous solution) (ammonia) is added. The mixture obtained is stirred at room temperature for 2 hours and then filtered.

[0174] Then product is concentrated to 866.18g, and 247.5g concentrated solution is transferred in glass reactor.In 1 hour, slowly add 371.3g methylene chloride.Precipitated NH4FSI is filtered, washed with methylene chloride, and dried in vacuum drying oven, to obtain 144.5g NH4FSI as white solid.

[0175] 110.12 g of crystalline NH4FSI was dissolved in 902.7 g of EMC. 23.37 g of a 25 wt.% aqueous solution of LiOH.H2O was added. The resulting biphasic mixture was stirred at room temperature for 1 hour and then decanted. The organic phase was recovered and precipitated under reduced pressure (10 -1 bar) and placed in a thin film evaporator at 60°C.

[0176] A solution of 30 wt.% LiFSI in EMC was obtained.

[0177] Example 2 - Preparation of LiFSI in powder form starting from the LiFSI solution of Example 1

[0178] use Figure 1 The equipment was set up and the detailed operating conditions summarized in Table 1 were used to perform the experiment with the following procedure.

[0179] The autoclave was filled with CO2 at the desired pressure (pressure = 80 to 200 bar) and temperature (temperature = 35°C-50°C) to provide supercritical CO2 (sCO2). During the experiment, sCO2 flowed continuously at a flow rate of 15-30 g / min (sCO2 flow rate = 15-30 g / min).

[0180] Pure EMC was then introduced (EMC flow rate = 0-0.7 mL / min) and mixed with sCO2 to obtain a steady state at the desired sCO2 / EMC mass ratio.

[0181] The EMC feed was replaced with the LiFSI solution of Example 1 (LiFSI solution flow rate = 0-2 mL / min). The injection of the LiFSI solution was performed continuously or discontinuously (30-120 seconds per injection).

[0182] Injection of pure CO2 is performed to dry the powder. After depressurization of the autoclave, a powder is obtained which is recovered through a filter.

[0183] Table 1 - Operating conditions for different experiments

[0184]

[0185]

[0186] result:

[0187] Experiment 10 produced 50% LiFSI salt (white and dry). It was obtained under the following conditions: 3 discontinuous LiFSI solution injections (30s / injection), pressure = 200 bar, temperature = 40°C, CO2 flow rate = 30 g / min, EMC flow rate = 0 mL / min, LiFSI solution flow rate = 2 mL / min, CO2 / LiFSI solution mass ratio = 30.

[0188] The water content was measured according to the KF analysis (oven method). The samples were prepared by a fully automatic oven sample processor (Metrohm); sample weight 0.1 g, carrier gas = N2, oven temperature = 160°C. The titration was performed using a mixture of methanol and NH4F (1:1 v / v). The polarization current for potentiometric determination of the reaction endpoint was 10 μA, and the titration endpoint voltage was 50 mV.

[0189] The water content in the LIFSI product of Experiment 10 was less than 50 ppm.

[0190] No major impurities were detected by ion chromatography (DIONEX ICS-3000):

[0191] -F - <20ppm

[0192] -Cl - <5ppm

[0193] - SO4 2- <15ppm

[0194] -NH2SO 3- n / d(not detected)

[0195] -FSO3 - n / d(not detected)

[0196] The purity was greater than 99.9% as determined by Li-NMR.

Claims

1. A method for preparing a lithium salt of bis(fluorosulfonyl)imide (LiFSI) in solid form, the method comprising the following steps: a) injecting a supercritical fluid into a container; b) optionally, injecting a solvent S into the container; c) injecting a LiFSI solution comprising LiFSI and at least one solvent S into the container; d) contacting the LiFSI solution with the at least one supercritical fluid and the solvent S in the container; and e) recovering LiFSI in solid form.

2. The method according to claim 1, wherein: The at least one supercritical fluid in step a) is selected from: one fluid in a supercritical state, or a mixture of at least two fluids in a supercritical state.

3. The method according to any one of claims 1 to 2, wherein: - step b) is not performed and step c) is started after step a); or - Step b) is performed, and step c) is started after step a) and step b), and the solvent S injected in step b) is the same as the solvent S in the LiFSI solution injected in step c).

4. The method according to any one of claims 1 to 3, wherein: The solvent S is selected from the group consisting of ethylene carbonate, propylene carbonate, butylene carbonate, γ-butyrolactone, γ-valerolactone, dimethoxymethane, 1,2-dimethoxyethane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,3-dioxane, 4-methyl-1,3-dioxolane, methyl formate, methyl acetate, methyl propionate, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, sulfolane, 3-methylsulfolane, dimethyl sulfoxide, N,N-dimethylformamide, N-methyloxazolidinone, acetonitrile, valeronitrile, benzonitrile, ethyl acetate, isopropyl acetate, n-butyl acetate, nitromethane, nitrobenzene, trifluoroethanol and mixtures thereof.

5. The method according to any one of claims 1 to 4, wherein: The solution contains between 5 and 70 wt. % LiFSI based on the total weight of the LiFSI solution.

6. The method according to any one of claims 1 to 5, wherein: The process is carried out in a vessel at a pressure P of at least 73 bar and / or at a temperature T between 30°C and 90°C.

7. A method according to any one of the preceding claims, wherein: The supercritical fluid comprises CO2, optionally mixed with at least one polar solvent having a solubility in the supercritical fluid of less than 10 wt.% based on the total weight of the supercritical fluid and the at least one polar solvent.

8. The method according to claim 7, wherein: - the pressure P in the container is comprised between 80 and 500 bar; and / or - The temperature in the container is comprised between 35°C and 80°C.

9. The method according to any one of claims 1 to 8, wherein: The process is carried out continuously or semi-continuously.

10. The method according to any one of claims 1 to 9, further comprising at least one step of recycling the solvent S and / or recycling the supercritical fluid.

11. The method according to any one of claims 1 to 10, which is carried out in an apparatus comprising: - Gas tanks and supercritical gas generators; -optionally, a solvent S tank; -LiFSI solution tank; - a container which can withstand a pressure P of at least 50 bar and a temperature P greater than 10° C.; - a device for mixing the supercritical fluid and the LiFSI solution; - at least two syringes mounted on the container; and -Solvent trap; -optionally, a separator; and - Optionally, a filtering device.

12. A lithium salt of bis(fluorosulfonyl)imide (LiFSI) in solid form obtainable by a process according to any one of claims 1 to 11, characterized in that It contains less than 100 ppm of water and / or less than 50 ppm of solvent S as measured according to the KF method (oven).

13. A powder comprising a lithium salt of bis(fluorosulfonyl)imide (LiFSI) and at least one other substance, wherein the at least one other substance is: - solvent S, preferably in an amount of less than 50 ppm as measured by Li NMR; and / or - water, preferably in an amount of less than 50 ppm as measured by KF analysis via the oven method; and / or -Fluoride ion (F - ), preferably in an amount of less than 25 ppm as measured by ion chromatography (IC); and / or -Chloride ion (Cl - ), preferably in an amount of less than 8 ppm as measured by IC; and / or -Sulfate (SO4 2- ), preferably in an amount of less than 20 ppm as measured by IC; and / or -Different from sulfate (SO4 2- ) of acidic substances, the amount of which is preferably less than 1 ppm as measured by IC.

14. Use of the lithium salt of bis(fluorosulfonyl)imide (LiFSI) according to claim 12 or the powder according to claim 13 in a battery electrolyte solution.

15. Use of supercritical anti-solvent extraction for preparing a lithium salt of bis(fluorosulfonyl)imide (LiFSI) in solid form from a solution comprising LiFSI and at least one solvent S.